ABCB1 and invasive ductal breast carcinoma: In contrast to our results and those published by Muggerud et al. [36] and Klajic et al. [38], Sharma et al. [35] have found the ABCB1 promoter to be hypomethylated in 47% of tumors from 100 invasive ductal breast carcinoma patients.